Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CORAL GABLES, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its third quarter 2024 financial results after the market close on Wednesday, November 6, 2024.

Catalyst's management team will host a conference call and webcast on Thursday, November 7, 2024, at 8:30 AM ET to discuss the Company's financial results and provide a business update.

Conference Call & Webcast Details

 

 

Date:

November 7, 2024

Time:

8:30 AM ET

US/Canada Dial-in Number:

800-715-9871

International Dial-in Number:

646-307-1963

 

 

The webcast will be accessible under the Investors section on the Company's website at ...